Compounds > melatonin
Page last updated: 2024-10-19

melatonin and Central Nervous System Neoplasm

melatonin has been researched along with Central Nervous System Neoplasm in 1 studies

Research Excerpts

ExcerptRelevanceReference
" In spite of its unfavorable biopharmaceutic properties, melatonin (MLT) has demonstrated anticancer effects against glioblastoma."7.91Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma. ( da Silva, ACG; de Oliveira Junior, ER; Lima, EM; Nascimento, TL; Salomão, MA; Valadares, MC, 2019)
" In spite of its unfavorable biopharmaceutic properties, melatonin (MLT) has demonstrated anticancer effects against glioblastoma."3.91Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma. ( da Silva, ACG; de Oliveira Junior, ER; Lima, EM; Nascimento, TL; Salomão, MA; Valadares, MC, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Oliveira Junior, ER1
Nascimento, TL1
Salomão, MA1
da Silva, ACG1
Valadares, MC1
Lima, EM1

Other Studies

1 other study available for melatonin and Central Nervous System Neoplasm

ArticleYear
Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma.
    Pharmaceutical research, 2019, Jul-01, Volume: 36, Issue:9

    Topics: Administration, Intranasal; Administration, Oral; Animals; Antineoplastic Agents; Brain; Cell Line,

2019